Report title: SWISS MEDICA INC.-DETAILED PRODUCT PIPELINE
from TF Market Research
15 page report published Oct 17, 2007

Price $600.00 available for immediate download
This report is also available for purchase on a per-page basis.
Report Overview
 
Purchase by Section
 
Search Inside
 
About TF Market Research

...Swiss Medica, Inc., a specialty pharmaceutical comp any, engages in the mark eting and distribution of bioscience health products with the focus on chroni c ailments. The company offers over-the-counter products that relieve pain and premenstrual synd rome. These products primarily include O## Pain Neutralizer that provides temporary relief for minor pains associated with arthritis, backaches, and other chronic pains; and O## Fibromyalgia for the patients suffering from fibromyalgia. The company also manufactures PMS Escape, an over-the -counter product for the treatme nt of mood and appetite symptoms associated with premenstrual syndrome. Swiss Medica has a strategic partnership with the National Fibromyalgia Association. The company sells its produc ts to healthcare professionals and athletes in the United States, Canada, and Europe. Swiss Medica markets its products through various distribution channels, including mass-food and drug retail outlets, in ternational sales, and...

Source: LIFE SCIENCE ANALYTICS
Author: HARINATHA, G.
Company: SWISS MEDICA INC
Geographic Regions: CANADA, NORTH AMERICA
Format:
PDF Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
Company Information11
Swiss Medica Inc. (OTC) Symbol : SWME11
Headquarters11
Fiscal Ends December11
Selected Financial Data11
Business Summary12
Product Glance41
MedTRACK Classification41
Product Pipeline51
Condition Treated51
Product Details52
Description61
Therapeutic62
Current Trial63
Last Updated64
3. PMS Escape61
Trial Details73
4. O24 Fibromyalgia pain reliever71
Drug Class81
6. Ayala81
Description81
Trademarks91
Deal Category: Miscellaneous91
Management Profile101
Bryson Farrill -- Chairman101
Raghu Kilambi -- Chief Executive Officer101
Grant Johnson -- President & Chief Operating Officer101
Bruce Fairbairn -- Chief Financial Officer101
Anne Dundon -- Vice President, Canadian Sales111
Robert Klein -- Vice President, Strategy111
Wendy Kramer -- Vice President111
Azim Fancy -- Director111
Sam Halim -- Director111
Charles Orr -- Director111
Ronald Springer -- Director121
Chris Broadhurst -- Medical Advisor121
Allan N. Fields -- Medical Advisor121
Gordon D. -- Medical Advisor121
Judith Wurtman -- Medical Advisor131
Recent Updates131
Company Announcements131
8/8/2007 -- Swiss Medica to Launch New USA Distribution Channel131
7/12/2007 -- Swiss Medica Launches New Multi-Channel Distribution Strategy For Canada131
9/19/2006 -- Swiss Medica Is Ranked #3 In Profit Magazine's Hot 50 Canadian Emerging Growth Companies131
6/8/2006 -- Swiss Medica Continues To Receive International Attention For O24 Fibromyalgia141
5/24/2006 -- Swiss Medica Announces that TVA Productions Media Campaign to Support O24 Fibromyalgia has Commenced141
Deals & Alliances141
9/14/2006 -- Swiss Medica Announces South Africa Distribution Deal For O24141
Product Update141
8/9/2006 -- Swiss Medica Launches O24 Private Label Product With Sierrasil141
Regulatory141
Distribution151

Enter the keyword(s) which you would like to search for within this document and click "Search"  


Price: $600.00



  Get FREE Research

Sign up here to receive email alerts for FREE Research from Alacra Partners!


  Can't Decide?

Purchasing premium research sight unseen can be intimidating. We want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.